|
|
|
|
LEADER |
01941nam a22004215i 4500 |
001 |
978-1-908517-08-1 |
003 |
DE-He213 |
005 |
20150521142820.0 |
007 |
cr nn 008mamaa |
008 |
111102s2010 xxk| s |||| 0|eng d |
020 |
|
|
|a 9781908517081
|9 978-1-908517-08-1
|
024 |
7 |
|
|a 10.1007/978-1-908517-08-1
|2 doi
|
040 |
|
|
|d GrThAP
|
050 |
|
4 |
|a RC681-688.2
|
072 |
|
7 |
|a MJD
|2 bicssc
|
072 |
|
7 |
|a MED010000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.12
|2 23
|
100 |
1 |
|
|a Lip, Gregory Y H.
|e author.
|
245 |
1 |
0 |
|a Handbook of Oral Anticoagulation
|h [electronic resource] /
|c by Gregory Y H Lip, Eduard Shantsila.
|
264 |
|
1 |
|a Tarporley :
|b Springer Healthcare Ltd. :
|b Imprint: Springer Healthcare,
|c 2010.
|
300 |
|
|
|a IX, 72p. 5 illus., 2 illus. in color.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
505 |
0 |
|
|a The coagulation pathway and approaches to anticoagulation -- Common clinical indications for anticoagulation -- The vitamin K antagonists and their limitations -- Haemorrhage risks, patient perspectives, and quality-of-life issues -- New oral anticoagulants -- Future directions.
|
520 |
|
|
|a An overview of the new oral warfarin alternatives, an important new area in therapy for cardiovascular disease, provided by a leading expert. Presented in a concise format Authored by a well-known expert Provides a user-friendly overview of the most important clinical trials.
|
650 |
|
0 |
|a Medicine.
|
650 |
|
0 |
|a Cardiology.
|
650 |
1 |
4 |
|a Medicine & Public Health.
|
650 |
2 |
4 |
|a Cardiology.
|
700 |
1 |
|
|a Shantsila, Eduard.
|e author.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
776 |
0 |
8 |
|i Printed edition:
|z 9781858734521
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-1-908517-08-1
|z Full Text via HEAL-Link
|
912 |
|
|
|a ZDB-2-SME
|
950 |
|
|
|a Medicine (Springer-11650)
|